Pfizer more than doubled the price of COVID-19 treatment drug Paxlovid
Drugmaker Pfizer said Wednesday that the price of its life-saving COVID-19 antiviral drug Paxlovid will more than double as the United States emerges from the emergency phase of the pandemic. The list price, before insurance, will be $1,390 for a five-day course, Pfizer said in a statement. This is 2.6 times higher than the $530/course … Read more